首页> 外文期刊>Nature >Boosting biotech in Finland
【24h】

Boosting biotech in Finland

机译:促进芬兰的生物技术

获取原文
获取原文并翻译 | 示例
           

摘要

Finland's science-funding situation seems enviable. This Nordic country has the second-highest per capita commitment to research of the 30 countries in the Organisation for Economic Co-operation and Development. It is second only to Sweden, with 3.5% of gross domestic product (GDP) going to research and development. Finland has a national venture-capital fund, to support start-up companies. And it has a public contract-research organization to provide expertise to both public and private institutions. But this small country, with its big commitment to research and development, is vulnerable in some respects — as its scientific leaders will cheerfully admit. Most of its research and development funding comes from the private sector, with 70% coming from the cellphone manufacturer Nokia. Public-sector funding is tipped almost two to one in favour of applied research. And career obstacles — such as the lack of a well-developed postdoc programme, a reliance on short-term funding for graduate students and the absence of a tenure track in universities — may limit the attractiveness of the country to both nationals and foreigners.
机译:芬兰的科学资助状况似乎令人羡慕。这个北欧国家的人均研究经济合作与发展组织中30个国家的研究投入最高。它仅次于瑞典,其国内生产总值(GDP)的3.5%用于研发。芬兰拥有国家风险投资基金,以支持初创公司。它有一个公共合同研究组织,可以为公共和私人机构提供专业知识。但是,这个小国对研究与开发有着巨大的承诺,但在某些方面却很脆弱-科学领导者会欣然承认。它的大部分研发资金来自私营部门,其中70%来自手机制造商诺基亚。公共部门的资助几乎两比一,以支持应用研究。而且职业障碍(例如,缺少完善的博士后计划,对研究生的短期资助依赖以及大学的终身任职轨迹等)可能会限制该国对国民和外国人的吸引力。

著录项

  • 来源
    《Nature》 |2004年第7011期|p.1020-1021|共2页
  • 作者

    Paul Smaglik;

  • 作者单位
  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 自然科学总论;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号